Julian Widder Selected Research

Julian Widder Research Topics

Disease

5	Heart Failure 03/2015 - 01/2004
5	Hypertension (High Blood Pressure) 07/2014 - 06/2004
3	Cardiomegaly (Heart Hypertrophy) 03/2015 - 03/2008
3	Myocardial Infarction 04/2009 - 01/2004
3	Cardiovascular Diseases (Cardiovascular Disease) 03/2008 - 01/2007
2	Aortic Valve Stenosis (Aortic Stenosis) 01/2023 - 01/2023
2	Inflammation (Inflammations) 10/2015 - 01/2004
2	Ventricular Remodeling 03/2015 - 01/2004
2	Atherosclerosis 12/2007 - 07/2006
1	Stroke (Strokes) 01/2022
1	Ischemic Stroke 01/2022
1	Atrial Fibrillation 11/2017
1	Tetralogy of Fallot (Fallot Tetralogy) 10/2016
1	Pulmonary Valve Insufficiency (Insufficiency, Pulmonary Valve) 10/2016
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 10/2016
1	Fibrosis (Cirrhosis) 03/2015
1	Left Ventricular Dysfunction 03/2015
1	Hypertrophy 03/2015
1	Disease Progression 03/2015
1	Venous Thromboembolism 01/2015
1	Ventricular Heart Septal Defects (Ventricular Septal Defect) 11/2013
1	Supraventricular Tachycardia 11/2013
1	Hypoxia (Hypoxemia) 12/2011
1	Reperfusion Injury 12/2011
1	Ischemia 12/2011
1	Myocardial Ischemia (Ischemic Heart Diseases) 12/2011
1	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 12/2011
1	Glucose Intolerance 07/2004

Drug/Important Bio-Agent (IBA)

3	Nitric Oxide (Nitrogen Monoxide)FDA Link 07/2014 - 06/2004
2	pro-brain natriuretic peptide (1-76)IBA 10/2016 - 11/2013
2	Brain Natriuretic Peptide (Natrecor)FDA Link 10/2016 - 10/2015
2	C-Reactive ProteinIBA 10/2015 - 12/2007
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2011 - 12/2007
2	salicylhydroxamic acid (SHAM)IBA 02/2010 - 07/2004
1	Metalloproteases (Metalloproteinases)IBA 01/2022
1	ThrombospondinsIBA 01/2022
1	DisintegrinsIBA 01/2022
1	tetrachloroisophthalonitrile (Bravo)IBA 11/2017
1	Biomarkers (Surrogate Marker)IBA 10/2015
1	Interleukin-8 (Interleukin 8)IBA 10/2015
1	Interleukin-6 (Interleukin 6)IBA 10/2015
1	Testosterone (Sustanon)FDA Link 03/2015
1	Finasteride (Propecia)FDA LinkGeneric 03/2015
1	EnzymesIBA 03/2015
1	Protein Isoforms (Isoforms)IBA 03/2015
1	AndrogensIBA 03/2015
1	Dihydrotestosterone (Androstanolone)IBA 03/2015
1	AnticoagulantsIBA 01/2015
1	Dexamethasone (Maxidex)FDA LinkGeneric 07/2014
1	Vasodilator Agents (Vasodilators)IBA 07/2014
1	Acetylcysteine (Siran)FDA LinkGeneric 12/2011
1	Thioredoxin Reductase 2IBA 12/2011
1	Thioredoxin-Disulfide ReductaseIBA 12/2011
1	Mitochondrial Permeability Transition PoreIBA 12/2011
1	Tamoxifen FDA LinkGeneric 12/2011
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 02/2010
1	Nitric Oxide Synthase (NO Synthase)IBA 02/2010
1	Desoxycorticosterone (Deoxycorticosterone)IBA 02/2010
1	Acetates (Acetic Acid Esters)FDA Link 02/2010
1	sapropterin (tetrahydrobiopterin)FDA Link 02/2010
1	4-fluoro-N-indan-2-yl-benzamideIBA 04/2009
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 04/2009
1	SaltsIBA 03/2008
1	vasodilator-stimulated phosphoproteinIBA 03/2008
1	LigandsIBA 03/2008
1	AldosteroneIBA 03/2008
1	Estrogen Receptor alphaIBA 03/2008
1	Estrogen Receptor betaIBA 03/2008
1	Peroxynitrous Acid (Peroxynitrite)IBA 12/2007
1	AntioxidantsIBA 01/2007
1	Apolipoproteins E (ApoE)IBA 07/2006
1	ApolipoproteinsIBA 07/2006
1	Proteins (Proteins, Gene)FDA Link 07/2004
1	Acetylcholine (Acetylcholine Chloride)FDA Link 07/2004
1	Acarbose FDA LinkGeneric 07/2004
1	p38 Mitogen-Activated Protein KinasesIBA 07/2004
1	MitogensIBA 07/2004
1	Nitroprusside (Sodium Nitroprusside)FDA LinkGeneric 07/2004
1	Phosphotransferases (Kinase)IBA 07/2004
1	Superoxides (Superoxide)IBA 07/2004
1	Pioglitazone (Actos)FDA Link 01/2004
1	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 01/2004
1	CollagenIBA 01/2004
1	PPAR gammaIBA 01/2004

Therapy/Procedure

3	Transcatheter Aortic Valve Replacement 01/2023 - 11/2017
2	Therapeutics 03/2015 - 07/2014
1	Secondary Prevention 01/2022
1	Patient Readmission 10/2015
1	Transplantation 11/2013
1	Nephrectomy 02/2010